151 related articles for article (PubMed ID: 10819103)
1. Management and outcome of glottic cancer: a population-based comparison between Ontario, Canada and the SEER areas of the United States. Surveillance, Epidemiology and End Results.
Groome PA; Mackillop WJ; Rothwell DM; O'Sullivan B; Irish JC; Hall SF; Warde PR; Holowaty EJ
J Otolaryngol; 2000 Apr; 29(2):67-77. PubMed ID: 10819103
[TBL] [Abstract][Full Text] [Related]
2. Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles?
Groome PA; O'Sullivan B; Irish JC; Rothwell DM; Math KS; Bissett RJ; Dixon PR; Eapen LJ; Gulavita SP; Hammond JA; Hodson DI; Mackenzie RG; Schneider KM; Warde PR; Mackillop WJ
J Clin Epidemiol; 2001 Mar; 54(3):301-15. PubMed ID: 11223328
[TBL] [Abstract][Full Text] [Related]
3. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
4. Defining the need for radiotherapy for lung cancer in the general population: a criterion-based, benchmarking approach.
Barbera L; Zhang-Salomons J; Huang J; Tyldesley S; Mackillop W
Med Care; 2003 Sep; 41(9):1074-85. PubMed ID: 12972847
[TBL] [Abstract][Full Text] [Related]
5. Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States.
Groome PA; O'Sullivan B; Irish JC; Rothwell DM; Schulze K; Warde PR; Schneider KM; Mackenzie RG; Hodson DI; Hammond JA; Gulavita SP; Eapen LJ; Dixon PF; Bissett RJ; Mackillop WJ
J Clin Oncol; 2003 Feb; 21(3):496-505. PubMed ID: 12560441
[TBL] [Abstract][Full Text] [Related]
6. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
7. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
8. Defining the need for breast cancer radiotherapy in the general population: a criterion-based benchmarking approach.
Kerba M; Miao Q; Zhang-Salomons J; Mackillop W
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):481-9. PubMed ID: 17467249
[TBL] [Abstract][Full Text] [Related]
9. Impact of surveillance on survival after laryngeal cancer in the medicare population.
Francis DO; Yueh B; Weymuller EA; Merati AL
Laryngoscope; 2009 Dec; 119(12):2337-44. PubMed ID: 19718759
[TBL] [Abstract][Full Text] [Related]
10. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
11. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
12. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.
Hoffman HT; Porter K; Karnell LH; Cooper JS; Weber RS; Langer CJ; Ang KK; Gay G; Stewart A; Robinson RA
Laryngoscope; 2006 Sep; 116(9 Pt 2 Suppl 111):1-13. PubMed ID: 16946667
[TBL] [Abstract][Full Text] [Related]
13. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prognosis of stage T3 glottic laryngeal cancer--a report of 65 cases].
Yu WB; Zeng ZY; Chen FJ; Peng HW
Ai Zheng; 2006 Jan; 25(1):85-7. PubMed ID: 16405757
[TBL] [Abstract][Full Text] [Related]
16. Quality of life, functional outcome, and costs of early glottic cancer.
Smith JC; Johnson JT; Cognetti DM; Landsittel DP; Gooding WE; Cano ER; Myers EN
Laryngoscope; 2003 Jan; 113(1):68-76. PubMed ID: 12514385
[TBL] [Abstract][Full Text] [Related]
17. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data.
Das A; Singh V; Fleischer DE; Sharma VK
Am J Gastroenterol; 2008 Jun; 103(6):1340-5. PubMed ID: 18510606
[TBL] [Abstract][Full Text] [Related]
18. Salvage surgery after radiotherapy for laryngeal cancer: from endoscopic resections to open-neck partial and total laryngectomies.
Piazza C; Peretti G; Cattaneo A; Garrubba F; De Zinis LO; Nicolai P
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1037-43. PubMed ID: 17938329
[TBL] [Abstract][Full Text] [Related]
19. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
20. Management and pitfalls of stage I/II glottic cancer.
Tateya I; Hirano S; Kitamura M; Kada S; Ishikawa S; Kanda T; Asato R; Tanaka S; Ito J
Acta Otolaryngol Suppl; 2010 Nov; (563):62-7. PubMed ID: 20879821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
